Evaluation of Elevated Lithium Levels
When evaluating elevated lithium levels, immediately obtain a serum lithium concentration, assess the patient's clinical status focusing on neurological symptoms, determine the pattern of toxicity (acute vs. chronic), and evaluate kidney function—these four elements together dictate management urgency and need for extracorporeal treatment. 1
Critical Initial Assessment
1. Measure Serum Lithium Level
- Draw blood 8-12 hours after the last dose when concentrations are at steady state 2
- Critical pitfall: Ensure blood is NOT drawn in a green-top (lithium heparin) tube, which will falsely elevate results 3
- Therapeutic range: 0.6-1.2 mEq/L 1, 2
- Toxicity thresholds:
- Mild: 1.5-2.5 mEq/L
- Moderate: 2.5-3.5 mEq/L
- Severe: >3.5 mEq/L 1
2. Classify the Pattern of Toxicity
This is essential because clinical symptoms correlate poorly with serum levels and vary dramatically by toxicity pattern 1:
- Acute poisoning (lithium-naïve patient with overdose): Often minimal symptoms despite markedly elevated levels due to delayed brain diffusion (takes ~24 hours) 1
- Acute-on-chronic (maintenance patient with acute overdose): Moderate symptoms with existing body burden
- Chronic toxicity (maintenance patient with gradual accumulation): Most dangerous—prominent symptoms can occur at levels as low as 1.5 mEq/L because brain lithium concentrations are already elevated 1
3. Perform Focused Neurological Examination
The CNS is the primary target organ, particularly in chronic toxicity 1:
Mild toxicity signs:
- Drowsiness, nausea, vomiting
- Tremor, hyperreflexia
- Agitation, muscle weakness, ataxia
Moderate to severe toxicity:
- Confusion or decreased level of consciousness
- Stupor, rigidity, hypertonia
- Seizures, myoclonus, coma
- Cardiopulmonary collapse
Key distinction: GI symptoms (nausea, vomiting, diarrhea) are prominent in acute poisoning but almost invariably absent in chronic toxicity 1
4. Assess Kidney Function
Impaired kidney function is critical because lithium is 100% renally excreted 1:
Define impaired function as:
- eGFR <45 mL/min/1.73m² (CKD stage 3B or worse)
- AKI stage 2 or 3
- Serum creatinine ≥2.0 mg/dL in adults, ≥1.5 mg/dL in elderly/low muscle mass 1
- Oliguria/anuria regardless of creatinine
5. Obtain Serial Measurements
- In acute phase: Check lithium levels twice weekly until stable 2
- After any dose change or clinical deterioration
- Monitor for rebound: Lithium redistributes from tissues back to serum over 12 hours after initial treatment, potentially requiring repeat intervention 1
Additional Diagnostic Workup
Identify Precipitating Factors
- Volume depletion (increases proximal tubule reabsorption) 1
- Drug interactions: NSAIDs, thiazide diuretics, ACE inhibitors, loop diuretics—all increase lithium levels 2
- Recent dose increase
- Decreased kidney function
- Dehydration from sweating, diarrhea, fever 2
Cardiac Evaluation
- ECG for: ST depression, bradycardia, sinus node dysfunction, T-wave inversions, life-threatening dysrhythmias 1
Laboratory Panel
- Electrolytes (sodium particularly—lithium mimics sodium biochemically)
- Thyroid function (chronic lithium causes hypothyroidism) 2
- Calcium/PTH (lithium causes hyperparathyroidism) 4
Common Pitfalls to Avoid
Don't rely solely on serum levels: A patient with chronic toxicity at 1.5 mEq/L may be more symptomatic than an acute overdose patient at 5.0 mEq/L 1, 5
Don't use lithium heparin tubes for blood draws 3
Don't ignore mild symptoms in chronic users: Even therapeutic levels can cause toxicity in elderly patients or those with declining kidney function 6, 7
Don't forget the 24-hour delay: Acute overdose patients may appear well initially but deteriorate as lithium distributes to the brain 1
Women and elderly are at higher risk for toxicity at any given level 6